搜尋
Theratechnologies Inc
THTX添加自選
3.390USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
155.87M總市值
虧損本益比TTM
關於 Theratechnologies Inc 公司
Theratechnologies Inc. 是一家總部位於加拿大的臨牀階段生物製藥公司。該公司專注於開發和商業化治療方案，以滿足未滿足的醫療需求。該公司在美國銷售針對人類免疫缺陷病毒 (HIV) 患者的處方產品。該公司的研究渠道專注於針對 HIV、非酒精性脂肪性肝炎 (NASH) 和腫瘤學領域未滿足的醫療需求的專門療法。其藥物包括 Trogarzo 和 EGRIFTA SV（注射用替莫瑞林）。Trogarzo（ibalizumab-uiyk）注射液是一種長效單克隆抗體，可與 CD4 T 細胞受體的結構域 2 結合。EGRIFTA SV（注射用替莫瑞林）在美國獲批用於減少患有脂肪營養障礙的 HIV 感染者腹部多餘脂肪。該公司的產品組合包括針對晚期卵巢癌患者的新型肽-藥物偶聯物 (PDC) 舒多西他賽禪度索肽 (TH1902) 的 I 期臨牀試驗。
Theratechnologies Inc簡介
公司代碼THTX
公司名稱Theratechnologies Inc
上市日期Dec 21, 1993
CEOMr. Paul Levesque
員工數量94
證券類型Ordinary Share
年結日Dec 21
公司地址2015 Peel Street, 11th Floor
城市MONTREAL
上市交易所NASDAQ Capital Market Consolidated
國家Canada
郵編H3A 1T8
電話15143367800
網址https://www.theratech.com/
公司代碼THTX
上市日期Dec 21, 1993
CEOMr. Paul Levesque
Theratechnologies Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
Ms. Dale Maccandlish Weil
Ms. Dale Maccandlish Weil
Independent Director
Independent Director
--
-100.00%
Mr. Andre Dupras
Mr. Andre Dupras
Vice President of Human Resources
Vice President of Human Resources
--
--
Ms. Elina Tea
Ms. Elina Tea
Independent Director
Independent Director
--
--
Mr. Andrew Thomas Molson
Mr. Andrew Thomas Molson
Independent Director
Independent Director
--
-100.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jocelyn Lafond
Mr. Jocelyn Lafond
General Counsel, Company Secretary
General Counsel, Company Secretary
--
-100.00%
Mr. Joseph P. Arena
Mr. Joseph P. Arena
Independent Director
Independent Director
--
--
Mr. John Leasure
Mr. John Leasure
Global Commercial Officer
Global Commercial Officer
--
-100.00%
Mr. Paul Levesque
Mr. Paul Levesque
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Mr. Frank A. Holler
Mr. Frank A. Holler
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
-100.00%
Dr. Christian Marsolais, Ph.D.
Dr. Christian Marsolais, Ph.D.
Senior Vice President, Chief Medical Officer
Senior Vice President, Chief Medical Officer
--
-100.00%
常見問題
Theratechnologies Inc的前五大股東是誰？
Theratechnologies Inc的前五大股東如下：Mr. Jocelyn Lafond
有多少機構持有Theratechnologies Inc(THTX)的股份？
截至2026Q1，共有78家機構持有Theratechnologies Inc的股份，合計持有的股份價值約為293.53K，占公司總股份的0.64% 。與2025Q4相比，機構持股有所增加，增幅為-22862543.00。
哪個業務部門對Theratechnologies Inc的收入貢獻最大？
在2026Q1，EGRIFTA業務部門對Theratechnologies Inc的收入貢獻最大，創收11.13M，占總收入的62.78% 。